Shipping:
FREE
Within U.S.A.
Book Description Condition: New. Book is in NEW condition. Seller Inventory # 1032098201-2-1
Book Description paperback. Condition: New. Language: ENG. Seller Inventory # 9781032098203
Book Description Paperback / softback. Condition: New. New copy - Usually dispatched within 4 working days. Seller Inventory # B9781032098203
Book Description Condition: New. New! This book is in the same immaculate condition as when it was published. Seller Inventory # 353-1032098201-new
Book Description Paperback. Condition: Brand New. 315 pages. 9.21x6.14x0.63 inches. In Stock. Seller Inventory # __1032098201
Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This reference describes applications of computational and molecular modeling techniques toward more efficient and affordable biopharmaceutical drug development at the pre-clinical stages that could positively impact clinical outcomes. With a primary focus on the developability of monoclonal antibody candidates, it addresses many contributions t. Seller Inventory # 9781032098203
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Sandeep Kumar, PhD, is a senior principal scientist at Pfizer, Inc. in the Biotherapeutics Pharmaceutical Sciences group, working on computational modeling and developability risk assessments of a wide variety of biotherapeutic drug cand. Seller Inventory # 487064758